Global /China /Healthcare /Drug Manufacturers - General /300119

Tianjin Ringpu Bio-Technology Co.,Ltd.

300119

• SHE: 300119 • Delayed

18.00CNY -0.8%

2.66 USD

As of 13 June 2026, Tianjin Ringpu Bio-Technology Co.,Ltd. has a market cap of $1.22B USD, ranking #9608 globally and #2608 in China. It ranks #833 in the Healthcare sector, and #315 in the Drug Manufacturers - General industry.

Global Rank

9608

Country Rank

2608

Sector Rank

833

Industry Rank

315

Key Stats

Market Cap

$1.22BUSD

8.24B CNY

Enterprise Value

$1.26BUSD

8.54B CNY

Revenue (TTM)

$502.21MUSD

3.4B CNY

EBITDA (TTM)

$87.17MUSD

590.41M CNY

Net Income (TTM)

$57.9MUSD

392.31M CNY

EBITDA Margin

17%

Profit Margin

12%

PE Ratio

21.0

Forward PE

19.1

PS Ratio

2.4

PB Ratio

1.6

EV/EBITDA

14.2

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Lei Xu open_in_new

Employees

2,900

Founded

1998

Website

ringpu.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-0.8%	-1.4%	-2.8%	-10%	-16%	-3.4%	-4.1%	-16%	-35%

News

Markets

Exchange	Ticker	Price	Quotes
Shenzhen Stock Exchange (SHE / SZSE) MIC: XSHE PRIMARY	300119 天津瑞普生物技术股份有限公司 Class A ISIN: CNE100000TV1 Shares Out.: Shares Outstanding: 464.755M¹ Shares Float: 464.398M² TV: TradingView: SZSE: 300119 SA: Stock Analysis: SHE: 300119 YF: Yahoo Finance: 300119.SZ GF: Google Finance: SHE: 300119 BA: Barron's: 300119 MS: Morningstar: XSHE: 300119	18.00 CNY	TV: TradingView: SZSE: 300119 SA: Stock Analysis: SHE: 300119 YF: Yahoo Finance: 300119.SZ GF: Google Finance: SHE: 300119 BA: Barron's: 300119 MS: Morningstar: XSHE: 300119

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Tianjin Ringpu Bio-Technology Co.,Ltd.

Tianjin Ringpu Bio-Technology Co.,Ltd. engages in the research and development, production, and sale of veterinary raw materials, pharmaceutical preparation, functional additives, and veterinary biological products. The company provides vaccines, chemical drugs, traditional Chinese medicines; feed additives, including pigs, chickens, waterfowl, cattle, sheep and pet medicines, and vaccines; and poultry, waterfowl, livestock, rumination, pets, washing and disinfection, active pharmaceutical ingredients product series. It also offers diagnosis and treatment services, such as epidemic diagnosis and testing, animal drug evaluation, and veterinary socialization. The company was founded in 1998 and is headquartered in Tianjin, China.

Similar Companies

Industry: Drug Manufacturers - General (China)

Name	Market Cap (USD) diff.	PE	Country
Jiangsu Hengrui Pharmaceuticals Co.,Ltd SSE: 600276	$53.85B 364.89B CNY 4K%	44.9	China
WuXi AppTec Co., Ltd. SSE: 603259	$49.64B 336.36B CNY 4K%	17.2	China
Hansoh Pharmaceutical Group Company Ltd. SHEK: 3692	$28.52B 223.48B HKD 2K%	35.7	China
Innovent Biologics, Inc. SHEK: 1801	$18.8B 147.32B HKD 1K%	162.3	China
Sichuan Biokin Pharmaceutical Co.,Ltd. SSE: 688506	$16.51B 111.89B CNY 1K%	-	China
Akeso, Inc. SHEK: 9926	$16.01B 125.46B HKD 1K%	-	China

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 63K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 45K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 30K%	97.4	United States
Roche Holding AG SIX: RO	$321.52B 256.25B CHF 26K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$288.84B 215.59B GBP 24K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$274.65B 218.9B CHF 22K%	20.5	Switzerland

chevron_leftBack